Background：B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272.
BTLA contains one Ig-like V-type (immunoglobulin-like) domain.
As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response.
BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.
仕様
サイズ：25ug
Source：Biotinylated Human BTLA (31-134), Fc,Avitag (BTA-H82F8) is expressed from human 293 cells (HEK293). It contains AA Lys 31 - Thr 134 (Accession # Q7Z6A9).
Molecule：BTLA
Synonyms：BTLA,CD272
Species：Human
Tag：Fc Tag & Avi Tag
Expression Systems：HEK293
Expression Rigeion：Lys 31 - Thr 134
Conjugate：Precision Avi
Molecular Weight：40.5 kDa
Characteristics：This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag). The protein has a calculated MW of 40.5 kDa. The protein migrates as 55-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level：Less than 1.0 EU per ug by the LAL method.
Purity：>95% as determined by SDS-PAGE.
Buffer：Tris with Glycine, Arginine and NaCl, pH7.5
